Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Sickle-cell disease, usually presenting in childhood, occurs more commonly in people (or their descendants) from parts of tropical and sub-tropical regions where malaria is or was common.

“Sickle cell disease impacts mostly people of Black or African descent. And we believe this is because, many many years ago, ...

Esther Nkemakolam runs her fingers through kinetic sand and sings a “Moana” song as UPMC Children’s Hospital nurse Taylor ...

Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

Feb. 25, 2025 — A bone marrow transplant process is safe and curative for adults with sickle cell disease, according to results of a trial completed at about 20 cancer ... Brains of People With ...

Recent research highlights the significant underuse of disease-modifying therapies for sickle cell disease, despite their ...

When Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters ...

NEW HAVEN, Conn. (WTNH) — News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing. According to the Pew Research Center, overall, 18% ...

“Sickle cell disease is placing a huge demand on blood transfusion services. We need to talk more about prevention, just as we do with malaria, maternal health, and road accidents,” she sai ...